Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

Clinical trial NCT05369000 · TERMINATED

Trial details

NCT number: NCT05369000
Sponsor: Lava Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration Resistant Prostate Cancer

Start date: 2022-01-17
Primary completion: 2025-06-18
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.